National Newswatch

False Premise: Federal Regulation of Drug Prices as a Step to National Pharmacare

Sep 9 2021 — Nigel Rawson and John Adams — In his National Newswatch commentary, Dr. Raza, another Canadian academic from that bastion of red socialism, argues for a national pharmacare program to be made affordable by drastically reducing drug prices by federal regulation. He uses data from an Angus Reid survey conducted with four academics from the Universities of British Columbia and Toronto and Carleton University who […]

A National Strategy for Drugs for Rare Diseases in Canada should Prioritize Patients – not Cost Containment

Mar 11 2021 — Nigel Rawson and John Adams — The 2019 federal budget raised hope for Canadians living with rare diseases by proposing to invest up to $1 billion over two years starting in 2022-23, with up to $500 million per year ongoing, in a national strategy for high-cost drugs for rare diseases. As a response to the recommendation of the Advisory Council on […]

Exempting COVID medicines from new price controls: Ottawa hypocrisy

Oct 14 2020 — Nigel Rawson and John Adams — The federal government intends to drastically transform the rules of its tribunal that sets ceiling prices for new drugs and vaccines in Canada in January. Guidelines will be released imminently for how the new price controls will work. Key elements of the government’s plan have been strongly criticized by patients, drug developers and analysts since […]